qnexa

Insomnia Information:Diet Drug Lorcaserin Safe, Effective, Study Finds,Get insomnia help.

Jul 14, 2010 … An experimental weight loss drug that targets the brain\’s hunger center was shown to be both safe and effective for helping dieters shed … . ,

Insomnia Information:Lorcaserin Successful in Treating Obesity ,what is Drugs MedNews,Get insomnia help.

Investigational drug Lorcaserin effectively helps obese people lose weight, according to a new report. In a recent study, people taking Lorcaserin … .drugs. ,

Insomnia Information:Lorcaserin and obesity,Get insomnia help.

Jul 14, 2010 … In addition to the weight loss with the selective serotonin 2C receptor agonist, an assessment of adverse events at one and two years did … . ,

Insomnia Information:New England Journal Shows Arena Pharma\’s (ARNA) lorcaserin …,Get insomnia help.

Lorcaserin also improved values for biomarkers that may be predictive of future … Lorcaserin patients who completed Year 1 of the BLOOM trial lost an …,

Insomnia Information:Experimental diet pill shows promise, little risk,Get insomnia help.

Arena Pharmaceuticals\’ lorcaserin is one of three drugs that are boosting hope … In the study, lorcaserin (lore-KASS-ah-rin) caused more people to lose at least …,

Insomnia Information:New England Journal of Medicine Publishes Results of Two-Year …,Get insomnia help.

today announced that results from the two-year BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial will be published in the…,

Insomnia Information:FDA Considering The Approval Of ARNA\’s Lorcaserin Benzinga,Get insomnia help.

Jun 3, 2010 … The analysts view an \”FDA panel as a big positive for the company as it implies the FDA is considering both approving lorcaserin and expects … . ,

Insomnia Information:Arena will launch lorcaserin with partner or alone Reuters,Get insomnia help.

Mar 12, 2010 … Expects 2010 spending to total $114 million * Spending assumes Arena pays for pre-launch activities By Deena Beasley LOS ANGELES, … .reuters.